Hysbysiad gwybodaeth ymlaen llaw
Cais am gystadleuaeth yw’r hysbysiad hwn
Adran I:
Endid
contractio
I.1) Enw a chyfeiriad
Porton Biopharma
Porton
SP4 0JG
UK
E-bost: jeff.pike@portonbiopharma.com
NUTS: UKK1
Cyfeiriad(au) rhyngrwyd
Prif gyfeiriad: https://portonbiopharma.bravosolution.co.uk
I.3) Cyfathrebu
Mae mynediad at y dogfennau caffael yn gyfyngedig. Gellir cael rhagor o wybodaeth yn:
https://portonbiopharma.bravosolution.co.uk
Gellir cael gwybodaeth ychwanegol o'r cyfeiriad uchod
Rhaid anfon tendrau neu geisiadau i gymryd rhan yn electronig at:
https://portonbiopharma.bravosolution.co.uk
Rhaid anfon tendrau neu geisiadau i gymryd rhan i'r cyfeiriad uchod:
I.4) Y math o awdurdod contractio
Corff a lywodraethir gan gyfraith gyhoeddus
I.5) Prif weithgaredd
Iechyd
Adran II: Gwrthrych
II.1) Cwmpas y caffaeliad
II.1.1) Teitl
PBL — 150083 PPC Zones 5 to 8 Reconfiguration Construction Expressions of Interest
II.1.2) Prif god CPV
45000000
II.1.3) Y math o gontract
Gwaith
II.1.4) Disgrifiad byr
This is a restricted procedure and organisations will need to sign a non-disclosure agreement before further information is supplied.
II.1.6) Gwybodaeth am lotiau
Mae’r contract hwn wedi’i rannu’n lotiau:
Na
II.2) Disgrifiad
II.2.2) Cod(au) CPV ychwanegol
44000000
II.2.3) Man cyflawni
Cod NUTS:
UKK1
II.2.4) Disgrifiad o’r caffaeliad
Porton biopharma Ltd are looking for a principal contractor to procure, construct and commission a 2-phased approach project within their live manufacturing facility. RIBA 4 design information will be available at invitation to tender during this procurement process.
The proposal will reconfigure/refurbish the existing biopharmaceutical manufacturing facility onsite at Porton down, the new arrangement will consist of Grade D and Grade C cleanrooms.
The project will consist of but not limited to:
1) Existing black utilities modification and reconfigurations;
2) Existing clean utilities modification and reconfigurations;
3) New clean steam, water for injection and purified water generation and distribution;
4) A mixture of client procured and principal contractor procured process equipment integration;
5) Demolition of existing areas i.e. internal wall, ceilings, all finishes, redundant services and equipment to enable reconfiguration and repurposing of the areas. Plantrooms and service area will also be in scope;
6) Liaison with PBL appointed designer and execution of contractor’s design portion;
7) Commissioning of the facility/equipment for handover to PBL to undertake any qualification that may be required;
8) Grade C processing room, cold rooms, storage rooms, with associated change room and material/equipment airlocks. Grade D equipment preparation room with associated change room and material/equipment airlocks.
The above is a brief overview of the project in question, more information will be provided at PQQ and subsequently ITT.
II.2.13) Gwybodaeth am Gronfeydd yr Undeb Ewropeaidd
Mae'r broses gaffael yn gysylltiedig â phrosiect a/neu raglen a ariennir gan gronfeydd yr Undeb Ewropeaidd:
Na
Section IV: Gweithdrefn
IV.1) Disgrifiad
IV.1.1) Y math o weithdrefn
Gweithdrefn gyfyngedig
IV.1.8) Gwybodaeth am Gytundeb Caffael y Llywodraeth (GPA)
The procurement is covered by the Government Procurement Agreement:
Ydy
IV.2) Gwybodaeth weinyddol
IV.2.2) Terfyn amser i ddatganiadau o ddiddordeb ddod i law
Dyddiad:
06/04/2020
Amser lleol: 17:00
IV.2.4) Ym mha iaith/ieithoedd y gellir cyflwyno tendrau neu geisiadau i gymryd rhan
EN
Section VI: Gwybodaeth ategol
VI.2) Gwybodaeth am lifau gwaith electronig
Defnyddir archebion electronig
Derbynnir anfonebau electronig
Defnyddir taliadau electronig
VI.4) Gweithdrefnau adolygu
VI.4.1) Corff adolygu
Porton Biopharma Ltd
Porton
UK
VI.5) Dyddiad anfon yr hysbysiad hwn
27/02/2020